🇺🇸 FDA
Pipeline program

TAK-360

TAK-360-2001

Phase 2 small_molecule active

Quick answer

TAK-360 for Narcolepsy Type 2 is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Narcolepsy Type 2
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials